The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

When a house catches on fire, we assume that a smoke alarm inside will serve one purpose and one purpose only: warn the ...

For millions living with nerve pain, even a light touch can feel unbearable. Scientists have long suspected that damaged ...

For most of us, everyday life is characterized by a lack of movement. But those long hours sitting at a desk, commuting by ...

Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...

Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye—called the ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis: Zug, Switzerland Thursday, January 8, 2026, 17:00 Hrs [IS ...

Expert says a well-balanced and whole-foods diet is the bedrock of brain health. If you're someone who wants to lower ...

A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...